Skip to main content
Premium Trial:

Request an Annual Quote

Febit Biotech, Epicentre Biotechnologies, NoAb BioDiscoveries

Premium
Febit Biotech this week launched its Geniom RT Analyzer system for sample hybridization, automated processing, and analysis.
 
The system is designed to be used in combination with Geniom biochips that have been synthesized on Febit’s Geniom One instrument in the customer’s lab, or purchased as Ready-to-Go Biochips directly from Febit.
 
The content of Geniom Ready-to-Go Biochips can be chosen from a portfolio of digital microarrays provided by Febit, or from public databases, amended or supplemented by additional genomic information specific to each customer, the company said.
 

 
Epicentre Biotechnologies last week launched its Moloney Murine Leukemia Virus Reverse Transcriptase 1st-Strand cDNA Synthesis Kit for generating full-length, first-strand cDNA from total RNA or purified polyadenylated RNA-enriched samples.
 
The kit features Epicentre's high activity formulation MMLV Reverse Transcriptase and 10X Reaction Buffer, which the firm claims enables the production of full-length cDNA longer than 15 kb from mRNA templates using an oligo primer.
 

 
NoAb BioDiscoveries last week launched DTEx, a microarray-based technology for profiling the effects of drugs on the expression of key proteins involved in drug disposition.
Specifically, Toronto-based NoAb is offering DTEx-ABC, a service for gene expression profiling of the human efflux drug transporters; DTEx-ADME for gene expression profiling of key human efflux and uptake drug transporters, Phase I and II metabolic enzymes, and nuclear factors; and DTEx-Custom for gene expression profiling of human genes selected by the client from the NoAb BioDiscoveries gene palette.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.